During the phase of rapamycin treatment, experimental animals have estrous cycle disorder, sudden weight loss, etc.69; the activity of the PTEN-PI3K-AKT pathway was enhanced in dividing tumor cells and stem cells, so either artificial inhibition or activation of those pathways will bring about unpredictable physiological risks. The gene discussed is PTEN; the disease is neoplasm.